FDA Approved: SUBOXONE — Supplemental Application (INDIVIOR INC.)

View source ↗

Summary

The FDA approved a supplemental application for SUBOXONE (buprenorphine/naloxone) from Indivior, enabling an update to its labeling/indication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• SUBOXONE (buprenorphine hydrochloride, naloxone hydrochloride)

Snippet

SUPPL AP for SUBOXONE (BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE)